Interpace Biosciences

+$4.43 (+113.01%) Today
$0.00 (0.00%) As of 8:30 PM UTC after-hours

Why Robinhood?

You can watch IDXG and buy or sell other stocks, options, and ETFs commission-free!

About IDXG

Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay.

CEO
Jack E. Stover
Employees
89
Headquarters
Parsippany, New Jersey
Founded
1986

IDXG Key Statistics

Market Cap
318.94M
Price-Earnings Ratio
0.00
Dividend Yield
0.00
Average Volume
573.44K
High Today
$8.85
Low Today
$7.51
Open Price
$7.51
Volume
12.03K
52 Week High
$8.85
52 Week Low
$0.381

You May Also Like

SCCB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure